医薬品医療機器等法に基づく新型コロナウイルスワクチンの特例承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_18787.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. Pro saves automatically start preparing the external RFC 3161 timestamp, and only unfinished records need one more preparation step before download.
医薬品医療機器等法に基づく新型コロナウイルスワクチンの特例承認について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page is an official announcement by Japan's Ministry of Health, Labour and Welfare dated May 21, 2021, regarding conditional approval of COVID-19 vaccines. Two vaccines received conditional approval under the Pharmaceutical Affairs Law: AstraZeneca's "Vaxzevria" and Takeda Pharmaceutical's "COVID-19 Vaccine Moderna." Both products are approved for preventing SARS-CoV-2 infection. The announcement includes product details, applicants, application dates, and indications.
